Gene · 2175
Papers3,803
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,761 to 1,780 of 3,803
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population. | BMC Urol | 2020 | 32811483 | PubTator, text mining | PubMed |
| Persistent Hypoglycemia in Seven-year-old Saudi Child: A Case Report. | Oman Med J | 2020 | 32802414 | PubTator, text mining | PubMed |
| Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia. | Genomics | 2020 | 32800766 | PubTator, text mining | PubMed |
| A scalable CRISPR/Cas9-based fluorescent reporter assay to study DNA double-strand break repair choice. | Nat Commun | 2020 | 32796846 | PubTator, text mining | PubMed |
| Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population - case report. | Mol Cytogenet | 2020 | 32793304 | PubTator, text mining | PubMed |
| Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma. | Front Genet | 2020 | 32793288 | PubTator, text mining | PubMed |
| Exome Sequencing Reveals Signal Transduction Genes Involved in Impulse Control Disorders in Parkinson's Disease. | Front Neurol | 2020 | 32793093 | PubTator, text mining | PubMed |
| S-Adenosylmethionine Treatment of Colorectal Cancer Cell Lines Alters DNA Methylation, DNA Repair and Tumor Progression-Related Gene Expression. | Cells | 2020 | 32784836 | PubTator, text mining | PubMed |
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment. | BMC Cancer | 2020 | 32778095 | PubTator, text mining | PubMed |
| Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway. | Breast Cancer Res Treat | 2020 | 32776290 | PubTator, text mining | PubMed |
| Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis. | Front Genet | 2020 | 32765594 | PubTator, text mining | PubMed |
| Acrylamide exposure represses neuronal differentiation, induces cell apoptosis and promotes tau hyperphosphorylation in hESC-derived 3D cerebral organoids. | Food Chem Toxicol | 2020 | 32763439 | PubTator, text mining | PubMed |
| The identification of six risk genes for ovarian cancer platinum response based on global network algorithm and verification analysis. | J Cell Mol Med | 2020 | 32762026 | PubTator, text mining | PubMed |
| Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes. | J Immunother Cancer | 2020 | 32759236 | PubTator, text mining | PubMed |
| Impact of hospitalisation on health-related quality of life in patients with chronic heart failure. | Health Qual Life Outcomes | 2020 | 32746842 | PubTator, text mining | PubMed |
| Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment-Current Progress, Strategy, and Future Perspective. | Front Immunol | 2020 | 32733486 | PubTator, text mining | PubMed |
| 2'-fluoro-modified pyrimidines enhance affinity of RNA oligonucleotides to HIV-1 reverse transcriptase. | RNA | 2020 | 32732393 | PubTator, text mining | PubMed |
| Structural insight into FANCI-FANCD2 monoubiquitination. | Essays Biochem | 2020 | 32725171 | PubTator, text mining | PubMed |
| Pre- and during- labour predictors of dystocia in active phase of labour: a case-control study. | BMC Pregnancy Childbirth | 2020 | 32723312 | PubTator, text mining | PubMed |
| Homologous repair deficiency score for identifying breast cancers with defective DNA damage response. | Sci Rep | 2020 | 32719318 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2175/papers?page=89